Document Detail


Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.
MedLine Citation:
PMID:  22391246     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A growing body of evidence suggests that peroxisome proliferator-activated receptor (PPAR) agonists are valuable candidates as disease modifiers in Parkinson's disease (PD) and may thus enable neuroprotection and preserve motor function. The present study sought to evaluate the effect of the PPAR-gamma agonist pioglitazone in two different animal models of PD. The study was based on nigral dopaminergic neuron labelling and the assessment of motor behaviour in (i) the frequently investigated MPTP mouse model and (ii) the less well-known bilateral 6-OHDA rat model. In MPTP-injected mice, pioglitazone reversed body weight loss and the reduction in rearing frequency and induced significant neuroprotection of the nigrostriatal dopaminergic pathway (by 24%, compared with vehicle). In contrast, pioglitazone did not have any effect on the 73.5% loss of dopaminergic neurons or motor impairments (a reduced rearing frequency and a loss of strength in the forepaws) in bilateral 6-OHDA rats. The PPAR-gamma agonist pioglitazone had a significant neuroprotective effect in MPTP mice but not in bilateral 6-OHDA rats. The various effects of PPAR agonists in both models can be accounted by the different action mechanism of the 2 toxins or by the fact that 3μg 6-OHDA injection was too harmful to be alleviated by the compound. This work supports PPAR-agonists to be relevant in the therapeutic strategy research in Parkinson's disease and highlights the importance in evaluating neuroprotective agent in different models.
Authors:
C Laloux; M Petrault; C Lecointe; D Devos; R Bordet
Related Documents :
9042526 - Distribution of fos-immunoreactivity in rat brain following a dipsogenic dose of captop...
3532826 - Salt appetite is suppressed by interference with angiotensin ii and aldosterone.
16129426 - Chronic beta-adrenoceptor stimulation and cardiac hypertrophy with no induction of circ...
15786726 - Effects of angiotensin-ii receptor blocker candesartan cilexetil in rats with dilated c...
17509226 - Nmda receptor and inos are involved in the effects of ginsenoside rg1 on hippocampal ne...
9299276 - Cigarette smoking increases endothelial-derived vasorelaxation in the rat carotid arter...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-2
Journal Detail:
Title:  Pharmacological research : the official journal of the Italian Pharmacological Society     Volume:  -     ISSN:  1096-1186     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907422     Medline TA:  Pharmacol Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Ltd.
Affiliation:
EA1046-Département de Pharmacologie médicale, IMPRT, Université Lille Nord de France, Faculté de médecine-pôle recherche, CHRU, 1 place de Verdun, F-59045 Lille cedex, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visual signal processing in the macaque lateral geniculate nucleus.
Next Document:  Are novel serum biomarkers informative?